Search for Clinical Trial Results

Sponsored By

Progeria - 5 Studies Found

Status Study
Enrolling by invitation Study Name: Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Date: 2009-06-05
Interventions: Drug: Lonafarnib, Zoledronic Acid, and Pravastatin Lonafar
Recruiting Study Name: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Condition: Progeria
Date: 2015-10-13
Interventions: Drug: Everolimus and lonafarnib
Completed Study Name: A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Condition: Progeria
Date: 2009-04-08
Interventions:
  • Drug: Lonafarnib Lonafarnib ca
Completed Study Name: Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Condition:
  • Progeria
  • Hutchinson-Gilford Syndrome Date: 2007-01-22
    Interventions: Drug: Lonafarnib Lonafarnib will be taken orally, twice per day, by all patients enrolled on this study.
Completed Study Name: Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
Condition: Hutchinson-Gilford Progeria Syndrome
Date: 2008-08-01
Interventions: Drug: Zoledronic acid, pravastatin Pravastatin : 10 mg dai